The size of the **transport media market **was USD 3,101.3 million in 2023, and it will grow at a rate of 4.6% by the end of this decade, to touch USD 4,210.6by 2030.
This is because of the growing occurrence of infectious ailments, for example herpes and influenza; rising requirement for pre-clinical and diagnostic testing, growing research and development on viral ailments, and growing count of initiatives by governments for driving the acceptance of testing kits.
Viral transport media category had 35% share in 2023. This is as a result of the unexpected eruption of communicable ailments, for example COVID-19 and monkeypox, which drives the requirement for analysis and testing amongst the infected people.
Furthermore, the snowballing consciousness of analysis and treatment throughout the COVID19 has augmented the requirement for the related products for the discovery of numerous other infections.
The viral diseases category leads the transport media market, on the basis of indication. Furthermore, this category will grow the fastest in the future. This is mostly as a result of the increasing burden of viral ailments, for example herpes, influenza, Varicella zoster, monkeypox, COVID-19, and respiratory syncytial virus.
Amongst them, the coronavirus and flu virus are the most-transmissible respiratory ailments and are, therefore, a serious cause for concern at a global level.
Diagnostic laboratories led the industry because of to the rising demand for diagnosis and testing for COVID-19. This has powered the setup of diagnostic labs and increased their workload. Also, alterations in the genome of the virus bring about changes in the viral structure, making normal vaccination ineffective.
Consequently, diagnostic labs are under pressure to not only identify the pathogen but also its precise disease-causing strain. Furthermore, to the snowballing consciousness of diagnostic testing, the assistance of governments to advance the healthcare system powers the industry.
The APAC region will grow the fastest, because of the snowballing incidence of infectious ailments, for example COVID-19, Lyme ailment, and TB. The populace riddled with infectious ailments is fairly large, particularly in India and China, which are the leading nations in this regard. Therefore, more than a few market players have come forward to justify the massive unmet necessity for diagnosis.
Europe holds a substantial share because of the large patient populace with infectious ailments. For example, in 2022, there was an outburst of the monkeypox virus. Likewise, in 2019, MERS-CoV and SARS-CoV advent was acknowledged by regional governments. Furthermore, the incessant surge in the incidence of influenza fast-tracks the industry growth.
It is because of the rising prevalence of infectious diseases all over the world, the demand for transport media solutions will continue to grow in the coming years as well.
SOURCE:P&S Intelligence